They noted that 31% (54/174) of BAP1 carriers were diagnosed with a uveal melanoma, 22% (39/174) had a malignant mesothelioma (26/39 of which were pleural), 13% (23/174) of cases had a cutaneous melanoma and 10% (18/174) had renal cell carcinoma. The gene discussed is BAP1; the disease is cutaneous melanoma.